Risk of peripheral edema in cancer patients receiving MET inhibitors: a systematic review and meta-analysis
{{output}}
Although MET inhibitors are increasingly used in cancer treatment, the overall risk and key determinants of treatment-related peripheral edema remain insufficiently characterized. We performed a systematic review and meta-analysis of randomized controlled tria... ...
